tariquidar has been researched along with lacosamide in 1 studies
| Studies (tariquidar) | Trials (tariquidar) | Recent Studies (post-2010) (tariquidar) | Studies (lacosamide) | Trials (lacosamide) | Recent Studies (post-2010) (lacosamide) |
|---|---|---|---|---|---|
| 210 | 16 | 138 | 727 | 90 | 625 |
| Protein | Taxonomy | tariquidar (IC50) | lacosamide (IC50) |
|---|---|---|---|
| Sodium channel protein type 3 subunit alpha | Rattus norvegicus (Norway rat) | 0.415 | |
| Sodium channel protein type 9 subunit alpha | Homo sapiens (human) | 0.182 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baum, L; Chanteux, H; Kwan, P; Zhang, C; Zuo, Z | 1 |
1 other study(ies) available for tariquidar and lacosamide
| Article | Year |
|---|---|
Potential role for human P-glycoprotein in the transport of lacosamide.
Topics: Acetamides; Animals; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Calcium Channel Blockers; Cell Line; Digoxin; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation; Humans; Lacosamide; Quinolines; Rhodamine 123; RNA, Messenger; Swine; Time Factors; Transfection; Tritium; Verapamil | 2013 |